Oral small peptides render HDL antiinflammatory in mice and monkeys and reduce atherosclerosis in ApoE null mice

Circulation Research

Volumn 97, Issue 6, 2005, Pages 524-532

  Navab, Mohamad ^a   Anantharamaiah, G M ^b   Reddy, Srinivasa T ^a   Hama, Susan ^a   Hough, Greg ^a   Frank, Joy S ^a   Grijalva, Victor R ^a   Ganesh, Vannakambadi K ^b   Mishra, Vinod K ^b   Palgunachari, Mayakonda N ^b   Fogelman, Alan M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

Atherosclerosis; High density lipoprotein; Lipid hydroperoxides; Peptides

Indexed keywords

ACETIC ACID ETHYL ESTER; AMINO ACID DERIVATIVE; ANTIOXIDANT; APOLIPOPROTEIN E; ARYLDIALKYLPHOSPHATASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROPEROXIDE; LIPOPROTEIN LIPID HYDROPEROXIDE; LYSYLARGINYLGLUTAMYLSERINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENZYME ACTIVITY; FEMALE; LIPID ANALYSIS; MOUSE; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN LIPID INTERACTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; ARYLDIALKYLPHOSPHATASE; FEMALE; HUMANS; LIPID PEROXIDATION; LIPOPROTEINS, HDL; MACACA FASCICULARIS; MICE; MICE, INBRED C57BL; OLIGOPEPTIDES;

EID: 25444520268     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000181229.69508.2f     Document Type: Article

References (23)

1. Epand RM, Gawish A, Iqbal M, Oupta KB, Chen CH, Segrest JP, Anantharamaiah GM. Studies of synthetic peptide analogs of the amphipathic helix. Effect of charge distribution, hydrophobicity, and secondary structure on lipid association and lecithin: cholesterol acyltransferase activation. J Biol Chem. 1987;262:9389-9396.
2. Anantharamaiah OM, Jones JL, Brouillette CO, Schmidt CF, Chung BI, Hughes TA, Bhown AS, Segrest JP. Studies of synthetic peptide analogs of the amphipathic helix. Structure of complexes with dimyristoyl phosphatidylcholine. J Biol Chem. 1985;260:10248-10255.
3. Venkatachalapathi YV, Phillips MC, Epand RM, Epand RF, Tytler EM, Segrest JP, Anantharamaiah OM. Effect of end group blockage on the properties of a class A amphipathic helical peptide. Proteins: Structure, Function and Genetics. 1993;15:349-359.
4. Datta O, Chaddha M, Kama S, Navab M, Fogelman AM., Garber DW, Mishra VK, Epand RM, Epand RF, Lund-Katz S, Phillips MC, Segrest JP, Anantharamaiah OM. Effects of increasing hydrophobicity on the physical-chemical and biological properties of a class A amphipathic helical peptide. J Lipid Res. 2001;42:1096-1104.
5. Navab M, Hama SY, Cooke C, Anantharamaiah GM, Chaddha M, Jin L, Subbanagounder G, Faull KF, Reddy S, Miller NE, Fogelman AM. Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1. J Lipid Res. 2000;41:1481-1494.
6. Navab M, Hama SY, Anantharamaiah OM, Hassan K, Hough GP, Watson AD, Reddy ST, Sevanian A, Fonarow GC, Fogelman, AM. Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3. J Lipid Res. 2000;41:1495-1508.
7. Navab M, Anantharamaiah OM, Hama S, Garber DW, Chaddha M, Hough O, Lallone R, Fogelman AM. Oral administration of an Apo A-I mimetic peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol. Circulation. 2002;105:290-292.
8. Navab M, Anantharamaiah OM, Reddy ST, Kama S, Hough O, Grijalva VR, Wagner AC, Frank JS, Datta O, Garber D, Fogelman AM. Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice. Circulation. 2004;109:3215-3220.
9. Navab M, Anantharamaiah GM, Reddy ST, Van Lenten BJ, Wagner AC, Hama S, Hough G, Garber DW, Mishra VK, Palgunachari N, Fogelman AM. An oral apoJ peptide renders HDL anti-inflammatory in mice and monkeys and dramatically reduces atherosclerosis in apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol. 2005;25 [Epub ahead of print].
10. Segrest JP, Jones MK, De Loof H, Brouillette CG, Venkatachalapathi YV, Anantharamaiah GM. The amphipathic helix in the exchangeable apolipoproteins; a review of secondary structure and function. J Lipid Res. 1992;33:141-166.
11. Navab M, Anantharamaiah GM, Reddy ST, Hama S, Hough G, Grijalva VR, Yu N, Ansell BJ, Datta G, Garber DW, Fogelman AM. Apolipoprotein A-I mimetic peptides. Arterioscler Thromb Vasc Biol. 2005;25:1325-1331.
12. Datta G, Epand RF, Epand RM, Chaddha M, Kirksey MA, Garber DW, Lund-Katz S, Phillips MC, Hama S, Navab M, Fogelman AM, Palgunachari MN, Segrest JP, Anantharamaiah GM. Aromatic residue position on the nonpolar face of class a amphipathic helical peptides determines biological activity. J Biol Chem. 2004;279:26509-26517.
13. Epand RM, Epand RF, Sayer BG, Datta G, Chaddha M, Anantharamaiah GM. Two homologous apolipoprotein AI mimetic peptides. Relationship between membrane interactions and biological activity. J Biol Chem. 2004;279:51404-51414.
14. Garber DW, Datta G, Chaddha M, Palgunachari MN, Hama SY, Navab M, Fogelman AM, Segrest JP, Anantharamaiah GM. A new synthetic class A amphipathic peptide analogue protects mice from diet-induced atherosclerosis. J Lipid Res. 2001;42:545-552.
15. Barlos K, Chatzi O, Oatos D, Stavropoulos O. 2-Chlorotrityl chloride resin. Studies on anchoring of Fmoc-amino acids and peptide cleavage. Int J Pept Protein Res. 1991;37:513-520.
16. Babiker E, Anantharamaiah OM, Royer OP, Means OE. Removal of benzyl type protecting groups from peptides by catalytic-hydrogenation with formic acid. J Org Chem. 1978;43:4196-4199.
17. Navab M, Hama S, Hough G, Fogelman AM. Oral synthetic phospholipid (DMPC) raises high-density lipoprotein cholesterol levels, improves high-density lipoprotein function, and markedly reduces atherosclerosis in apolipoprotein Å-null mice. Circulation. 2003;108:1735-1739.
18. Zhang YZ, Zanotti I, Reilly MP, Olick JM, Rothblat GH, Rader DJ. Overexpression of apolipoprotein A-I promotes reverse transport of cholesterol from macrophages to feces in vivo. Circulation. 2003;108:661-663.
19. Frank JS, Fogelman AM. Ultrastructure of the intima in WHHL and cholesterol-fed rabbit aortas prepared by ultra-rapid freezing and freeze-etching. J Lipid Res. 1989;30:967-978.
20. Navab M, Anantharamaiah GM, Reddy ST, Van Lenten BJ, Ansell BJ, Fonarow GC, Vahabzadeh K, Hama S, Hough O, Kamranpour N, Berliner JA, Lusis AJ, Fogelman AM. The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL. J Lipid Res. 2004;45:993-1007.
21. Ramesh CV, Jayakumar R, Puvanakrishnan R. A novel surface-active peptide derivative exhibits in vitro inhibition of platelet aggregation. Peptides. 1998;19:1695-1702.
22. Kumar DA, Manikandan P, Sumitra M, Raju KVSN, Oayathri C, Arutselvan N, Puvanakrishnan R. A novel peptide derivative exhibits anti inflammatory and antioxidant activity in adjuvant induced arthritis in rats. Mol Cell Biochem. 2002;229:9-17.
23. Forte TM, Subbanagounder O, Berliner JA, Blanche PJ, Clermont AO, Jia Z, Oda MN, Krauss RM, Bielicki JK. Altered activities of anti-atherogenic enzymes LCAT, paraoxonase, and platelet-activating factor acetylhydrolase in atherosclerosis-susceptible mice. J Lipid Res. 2002;43:477-485.